Sinotherapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Sinotherapeutics has a total shareholder equity of CN¥1.2B and total debt of CN¥63.3K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CN¥1.4B and CN¥152.5M respectively. Sinotherapeutics's EBIT is CN¥72.9M making its interest coverage ratio -7.6. It has cash and short-term investments of CN¥738.4M.
Key information
0.005%
Debt to equity ratio
CN¥63.26k
Debt
Interest coverage ratio | -7.6x |
Cash | CN¥738.42m |
Equity | CN¥1.20b |
Total liabilities | CN¥152.47m |
Total assets | CN¥1.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688247's short term assets (CN¥945.5M) exceed its short term liabilities (CN¥95.1M).
Long Term Liabilities: 688247's short term assets (CN¥945.5M) exceed its long term liabilities (CN¥57.3M).
Debt to Equity History and Analysis
Debt Level: 688247 has more cash than its total debt.
Reducing Debt: 688247's debt to equity ratio has increased from 0% to 0.01% over the past 5 years.
Debt Coverage: 688247's debt is well covered by operating cash flow (36595.3%).
Interest Coverage: 688247 earns more interest than it pays, so coverage of interest payments is not a concern.